CSIMarket
 


Biospecifics Technologies Corp  (BSTC)
Other Ticker:  
 
 

BSTC's Net Cash Flow Growth by Quarter and Year

Biospecifics Technologies's Net Cash Flow results by quarter and year




BSTC Net Cash Flow (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - -8.18 -0.20 0.91
III Quarter September -14.00 0.00 0.42 -2.61
II Quarter June -2.26 -4.42 0.40 4.27
I Quarter March 14.14 4.42 5.23 0.02
FY   -2.12 -8.18 5.85 2.59



BSTC Net Cash Flow third quarter 2020 Y/Y Growth Comment
Biospecifics Technologies Corp in the third quarter 2020 recorded net cash outflow of $ -14.00 millions.

According to the results reported in the third quarter 2020, Biospecifics Technologies Corp achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Biospecifics Technologies Corp' s Net Cash Flow no change of % ranks overall at the positon no. in the third quarter 2020.




BSTC Net Cash Flow ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - -90.63 % -2.51 %
I Quarter March 219.91 % -15.49 % 26050 % -
FY   - - 125.87 % -

Financial Statements
Biospecifics Technologies's third quarter 2020 Net Cash Flow $ -14.00 millions BSTC's Income Statement
Biospecifics Technologies's third quarter 2019 Net Cash Flow $ 0.00 millions Quarterly BSTC's Income Statement
New: More BSTC's historic Net Cash Flow Growth >>


BSTC Net Cash Flow (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - - - -
III Quarter September - - 5 % -
II Quarter June - - -92.35 % 21250 %
I Quarter March - - 474.73 % -
FY (Year on Year)   - - 125.87 % -




Net Cash Flow third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Biospecifics Technologies's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BSTC's III. Quarter Q/Q Net Cash Flow Comment
Recent accomplishment of -14.00 millions by Biospecifics Technologies Corp appear even worse considering the net cash outflow -2.26 millions a quarter before.

Within Major Pharmaceutical Preparations industry Biospecifics Technologies Corp achieved highest sequential Net Cash Flow growth. While Biospecifics Technologies's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BSTC's III. Quarter Q/Q Net Cash Flow Comment
Current accomplishment of -14.00 millions by Biospecifics Technologies Corp come out even more unfavourable considering the net cash outflow -2.26 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Biospecifics Technologies Corp achieved highest sequential Net Cash Flow growth. While Biospecifics Technologies's Net Cash Flow growth quarter on quarter, overall rank is .


Biospecifics Technologies's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
Cumulative Net Cash Flow 12 Months Ending $ -10.30 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment
Biospecifics Technologies Corp' has realized cumulative trailing twelve months net cash outflow of $ -10 millions in the Sep 30 2020 period.
The business is detiriorating as the cumulative net cash outflow is getting bigger from $ 0 millions in the twelve months ending a quarter before and $ 0.215977 millions from the TTM period ending Sep 30 2019.

Biospecifics Technologies Corp achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment
Biospecifics Technologies Corp' has realized cumulative trailing twelve months net cash outflow of $ -10 millions in the Sep 30 2020 period.
The business is getting worse as the cumulative net cash outflow is inflating from $ 0 millions in TTM ending quarter Jun 30 2020 and $ 0.215977 millions from the TTM period ending Sep 30 2019.

Biospecifics Technologies Corp achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BSTC's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BSTC's Competitors
Net Cash Flow Growth for Biospecifics Technologies's Suppliers
Net Cash Flow Growth for BSTC's Customers

You may also want to know
BSTC's Annual Growth Rates BSTC's Profitability Ratios BSTC's Asset Turnover Ratio BSTC's Dividend Growth
BSTC's Roe BSTC's Valuation Ratios BSTC's Financial Strength Ratios BSTC's Dividend Payout Ratio
BSTC's Roa BSTC's Inventory Turnover Ratio BSTC's Growth Rates BSTC's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Sep 30 2020 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Sep 30 2020
Reliv International Inc-2.10%$ -2.099 millions
Nu med Plus Inc -6.63%$ -6.627 millions
Gilead Sciences Inc -8.36%$ -8.358 millions
Utah Medical Products Inc-12.65%$ -12.652 millions
Ufp Technologies Inc -16.07%$ -16.074 millions
Ptc Therapeutics inc -16.50%$ -16.495 millions
Motus Gi Holdings Inc -16.55%$ -16.546 millions
Novocure Limited-18.11%$ -18.113 millions
Irhythm Technologies Inc -26.37%$ -26.374 millions
Radnet Inc -28.23%$ -28.229 millions
Pacira Biosciences inc -35.85%$ -35.853 millions
Heartbeam Inc -36.86%$ -36.862 millions
Atreca inc -37.27%$ -37.268 millions
Crispr Therapeutics Ag-38.50%$ -38.505 millions
Progyny Inc -39.33%$ -39.326 millions
Innoviva Inc -40.25%$ -40.246 millions
Sorrento Therapeutics Inc -48.56%$ -48.559 millions
Integra Lifesciences Holdings Corp-48.95%$ -48.949 millions
Teligent Inc -53.03%$ -53.028 millions
Acadia Pharmaceuticals Inc -54.38%$ -54.376 millions
Standard Biotools Inc -57.68%$ -57.679 millions
Seelos Therapeutics inc -60.62%$ -60.623 millions
Rhythm Pharmaceuticals inc -61.25%$ -61.249 millions
Mallinckrodt Plc-62.08%$ -62.082 millions
Gw Pharmaceuticals Plc-64.51%$ -64.512 millions
Abbvie inc -65.80%$ -65.796 millions
Exicure Inc -67.68%$ -67.680 millions
Incyte Corporation-68.19%$ -68.194 millions
Frequency Therapeutics Inc -71.17%$ -71.167 millions
Homology Medicines Inc-73.31%$ -73.309 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com